Panobinostat: a novel pan-deacetylase inhibitor for the treatment of relapsed or relapsed and refractory multiple myeloma-Reference-Cited by-同舟云学术

Panobinostat: a novel pan-deacetylase inhibitor for the treatment of relapsed or relapsed and refractory multiple myeloma

Published:2015-06-07 Issue:7 Volume:15 Page:737-748
ISSN:1473-7140
Container-title:Expert Review of Anticancer Therapy
language:en
Short-container-title:Expert Review of Anticancer Therapy

Author:

Richardson Paul G,Laubach Jacob P,Lonial Sagar,Moreau Philippe,Yoon Sung-Soo,Hungria Vânia TM,Dimopoulos Meletios A,Beksac Meral,Alsina Melissa,San-Miguel Jesús F

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Oncology

Link

http://www.tandfonline.com/doi/pdf/10.1586/14737140.2015.1047770

Reference30 articles.

1. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma

2. Multiple Myeloma

3. Cancer statistics, 2014

4. Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study

5. Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibition of glutaminolysis alone and in combination with HDAC inhibitor has anti-myeloma therapeutic effects;Cancer Drug Resistance;2024-06-24

2. Lineage-specific proteome remodeling of diverse lung cancer cells by targeted epigenetic inhibitors;2024-05-28

3. HDAC Inhibition Sensitize Hepatocellular Carcinoma to Lenvatinib via Suppressing AKT Activation;International Journal of Biological Sciences;2024

4. Recent Developments in the Synthesis and Anticancer Activity of Indole and Its Derivatives;Current Organic Synthesis;2023-06

5. Upregulated spinal histone deacetylases induce nociceptive sensitization by inhibiting the GABA system in chronic constriction injury-induced neuropathy in rats;2023-03-22